KIMBERLY POWERS: Open Payments
NPI 1447913736 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 36 payments from 15 companies in 2025. Trend: 2023 $693 · 2024 $2,433 · 2025 $956
Food & beverage: $871Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $273 |
| Endo USA, Inc. | 6 | $153 |
| ACCORD HEALTHCARE, INC. | 6 | $136 |
| TOLMAR, INC. | 3 | $62 |
| PFIZER INC. | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Antares Pharma, Inc. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Dendreon Pharmaceuticals LLC | 1 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
Products named: RYBREVANT, Camcevi, ERLEADA, AVEED, XTANDI, Nubeqa, ELIGARD, XYOSTED.
Industry payments across IN — which companies pay providers there.
